Toward the end of trading Monday, the Dow traded up 0.82% to 34,152.49 while the NASDAQ fell 0.36% to 13,912.07. The S&P also rose, gaining 0.41% to 4,198.29.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,421,920 cases with around 577,040 deaths. India confirmed a total of at least 19,925,510 cases and 218,950 deaths, while Brazil reported over 14,754,910 COVID-19 cases with 407,630 deaths. In total, there were at least 152,903,900 cases of COVID-19 worldwide with more than 3,203,490 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares climbed by 2.5% on Monday. Meanwhile, top gainers in the sector included CONSOL Energy Inc. CEIX, up 15%, and Peabody Energy Corporation BTU, up 15%.
In trading on Monday, consumer discretionary shares fell 0.5%.
Top Headline
The Estée Lauder Companies Inc. EL reported stronger-than-expected earnings for its third quarter, while sales missed views.
Estee Lauder reported quarterly earnings of $1.62 per share, beating analysts’ estimates of $1.31 per share. The company’s quarterly sales came in at $3.86 billion, missing expectations of $3.93 billion.
Estee Lauder said it sees FY21 EPS growth of 45%-47%, and sales growth of 11%-12%.
Equities Trading UP
Ocugen, Inc. OCGN shares shot up 20% to $15.21 after the company announced that in a new study, COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2.
Shares of Brooklyn ImmunoTherapeutics, Inc. BTX got a boost, shooting 31% to $65.30 as the stock continued to increase in popularity on the subreddit r/wallstreetbets. On Friday, Brooklyn ImmunoTherapeutics filed a Form 8-K showing that it entered into a purchase agreement with Lincoln Park Capital on Apr. 26 in which the company can sell up to $20 million of common shares to the Chicago-based investment group and asset management firm. Additionally, Nicholas J Singer disclosed that he took a 9%-plus stake in the company in a 13G filing on Friday.
Milestone Scientific Inc. MLSS shares were also up, gaining 19% to $2.9950. Milestone Scientific reported preliminary Q1 sales of $2.9 million up from $1.8 million.
Check out these big movers of the day
Equities Trading DOWN
Vaxart, Inc. VXRT shares tumbled 26% to $7.97 after the company reported a wider Q1 loss.
Shares of Novavax, Inc. NVAX were down 16% to $198.86 despite the company initiating a pediatric expansion for its COVID-19 vaccine trial. Weakness is potentially due to profit taking after the stock surged last week following multiple positive catalysts.
AVROBIO, Inc. AVRO was down, falling 16% to $9.78 after the company provided an update on its regulatory plans for AVR-RD-01, its lentiviral gene therapy for Fabry disease, currently in FAB-GT Phase 2 trial. SVB Leerink analyst Mani Foroohar maintained Avrobio with a Market Perform and lowered the price target from $18 to $10.
Commodities
In commodity news, oil traded up 1.5% to $64.51, while gold traded up 1.4% to $1,792.40.
Silver traded up 4.3% Monday to $26.995 while copper rose 1.4% to $4.5305.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 gained 0.58%, the Spanish Ibex Index rose 0.89% and the German DAX 30 gained 0.66%. Meanwhile, the French CAC 40 rose 0.61% and Italy’s FTSE MIB climbed 1.15%.
The IHS Markit Eurozone manufacturing PMI rose to 62.9 in April from March's final level of 62.5. Germany’s manufacturing PMI slipped to 66.2 in April from a record high level of 66.6 in March, while French manufacturing PMI declined to 58.9 in April from 59.3 in March. Spain’s manufacturing PMI gained to 57.7 in April, compared to 56.9 in the earlier month.
Economics
The IHS Markit manufacturing PMI was revised lower to 60.5 in April from a preliminary reading of 60.6.
The ISM manufacturing PMI declined to 60.7 in April from 64.7 in March.
Construction spending rose 0.2% to an annual rate of $1.51 trillion in March.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
